The ‘Delta Plus’ variant has spread to nearly 30 countries, but low case numbers are a sign it won’t overtake Delta

south korea covid testing
A coronavirus testing station in Seoul, South Korea on August 26, 2020.

  • The Delta Plus variant is the Delta variant with an extra mutation. It has reached nearly 30 countries.
  • It’s not yet clear whether Delta Plus is more transmissible than Delta.
  • The fact that Delta remains dominant worldwide is a sign that Delta Plus won’t overtake it soon.
  • See more stories on Insider’s business page.

As the Delta variant tears across the globe, scientists are keeping a close eye on its relative: Delta Plus.

The two variants are genetically similar, which is why they share the same Greek letter. But Delta Plus (also known as AY.1) has an extra mutation in the code for its spike protein, which helps the coronavirus gain entry to our cells.

India’s health ministry said last month that Delta Plus appears to spread more easily than Delta, and can potentially bind more easily to lung cells or resist antibody drugs. But an Indian genomics consortium suggested more recently that Delta’s sub-lineages probably aren’t more transmissible than Delta itself. As of July 23, India had recorded no more than 70 Delta Plus cases.

Both the US Centers for Disease Control and Prevention and World Health Organization still track Delta Plus as part of the Delta variant, meaning the cases aren’t separated. But data from Scripps Research’s tracker suggests that just 430 Delta Plus cases have been detected worldwide.

South Korea announced Tuesday that it had recorded its first two cases of Delta Plus. The nation is battling its heaviest surge of infections yet, most likely driven by the original Delta strain.

“It doesn’t terrify me any more, really, than Delta,” Andrew Read, who studies the evolution of infectious diseases at Pennsylvania State University, said of Delta Plus.

Although Delta Plus has made its way to around 29 countries and 17 US states so far, Read noted that “the widespread geographic nature doesn’t mean that it’s one thing spreading widely.”

“It could be that it’s several independent events that are spreading locally,” he said.

In the US, Delta Plus cases peaked in late June, though they still represented less than 5% of the nation’s sequenced cases at that time, according to Health experts say that’s a sign that Delta Plus isn’t outcompeting other variants.

“If it started to rise in frequency against the Delta variant, that would tell you that it was perhaps on track to take over from Delta – but we’re not really seeing that at the moment,” Read said. “If it had a big advantage, we’d be seeing it rising in frequency pretty rapidly.”

Scientists don’t know how well vaccines perform against Delta Plus

Jason Rodriguez, a University of Florida Pharmacy student, gives Camila Gutierrez, 21, a junior at Florida International University from Bolivia, the Pfizer COVID-19 vaccine in Miami, April 15, 2021.

For Delta Plus to be a serious concern, scientists would need concrete evidence that it’s more transmissible than Delta, causes more severe disease, or resists protection from vaccines to a greater degree.

“I could imagine that, because the mutation is in the spike [protein], it might have some advantages in terms of immune evasion and some disadvantages in terms of binding to the ACE2 receptor,” Read said. That receptor serves as the port of entry for the coronavirus.

But Public Health England told Insider in June that there was no evidence that Delta Plus’s extra mutation made the virus any more severe or reduced vaccine effectiveness relative to Delta.

While Delta seems to have challenged how well vaccines prevent infection and transmission, coronavirus shots still reduce the risk of getting COVID-19 eight-fold, and the risk of hospitalization or death 25-fold, according to recent data from the CDC.

A study in the New England Journal of Medicine found that Pfizer’s two-dose vaccine reduces the risk of a symptomatic Delta infection by 88%. Another study that hasn’t been peer reviewed found Pfizer and Moderna’s mRNA vaccines reduce the risk of hospitalization by 91% for people who aren’t immunocompromised.

When it comes to Delta Plus, a study from Indian researchers that’s still awaiting peer review found that Covaxin – one of India’s two main coronavirus vaccines – still neutralizes the variant. Covaxin is similar to China’s Sinovac shot.

Read the original article on Business Insider

Facebook co-founder Eduardo Saverin is in talks to invest in CoinDXC that will seal the Indian crypto exchange’s unicorn status, report says

Eduardo Saverin speaks at the Tech in Asia Singapore 2016
Eduardo Saverin, co-founder at B Capital Group.

Facebook co-founder Eduardo Saverin’s B Capital is in discussions to close an investment round for Indian crypto exchange CoinDCX that could value the company at more than $1 billion, the Economic Times reported on Wednesday.

San Francisco-based digital asset investment fund Polychain Capital and crypto exchange Coinbase’s venture capital arm are other participants in the round that could raise between $100 to $120 million, the report said, citing three sources familiar with the matter.

For startups to attain a $1 billion valuation was once an uncommon feat, hence why they share a name with a rare mystical animal – “unicorn.”

B Capital, Polychain Capital, Coinbase Ventures, and CoinDCX didn’t immediately respond to Insider’s request for comment.

CoinDCX, launched in 2018, counts over 100,000 active monthly users and sees more than $40 million in daily trading volume, according to figures on its website. The company’s user base has surged 700% since March 2020, and its registered users reportedly stood at 1.5 million as of June.

Co-founders Sumit Gupta and Neeraj Khandelwal raised about $20 million through three rounds of funding in 2020, according to the ET.

CoinDCX’s billion-dollar status would make it the country’s first crypto unicorn, the report said.

The absence of clear regulations and a previous threat of a blanket ban on cryptocurrencies has kept some local investors away from crypto-focused firms, but the industry has managed to secure investments from international funds and entrepreneurs like Mark Cuban.

Indian crypto firm Polygon received an undisclosed investment from Cuban in May this year.

Cryptocurrency investments in India grew from about $200 million to nearly $40 billion in the 12 months to June, according to data firm Chainalysis. The country ranks as high as 11 out of 154 nations in terms of cryptocurrency adoption, data shows.

Read More: Denmark’s most popular eToro trader breaks down how his time as an elite chess player helped shape the strategy that made him 400% returns on bitcoin this year and led 20,000 people to copy his portfolio

Read the original article on Business Insider

Bhushan Kumar Net Worth in 2021 (T-Series Owner)

Last Updated on July 22, 2021 by Justin Su

Do you know Bhushan Kumar? and his net worth? Don’t know? Here are the details.

At I have already published many articles on different topics related to how to make money online but today in this article we are going to talk about Bhushan Kumar’s Net Worth.

If you are an Indian, you might know about him from a recent online fight between Pewdipie vs T-Series. In my opinion, it was a clearly baseless fight, there should no comparison between an Individual and Company.

Bhushan Kumar is the son of Gulshan Kumar, Gulshan Kumar was the founder of T-Series, and Bhushan Kumar is the current CEO of T-Series.

T-Series was founded in 1983 by Gulshan Kumar in Delhi. The T-Series has more than 188 million subscribers on YouTube.

Bhushan Kumar has a huge fan following and their followers are growing as well. But it doesn’t affect his net worth, the thing which affects is his channel and movie songs. Almost every week new song, trailer, or teaser is getting uploaded on the T-Series channel.

As per the report, Bhushan Kumar’s net worth is around $50 million. His net worth may be more than what we mention here as we are not sure how much net worth is.

Also, his net worth was $50 million as reported in 2020 and the same in 2021.

About Bhushan Kumar

Born: 27 November 1977 (age 43)

Birthplace: Delhi, India

Height: 5’9” tall (175 cm)

Occupation: Film Producer and Music Producer

Also Read: People Per Hour Test Answers

Also Read: How To Make Money On Youtube

Years Active: 1998 to present

Designation: Chairman and MD of Super Cassettes Industries Limited, known as T-Series.

Wife: Divya Khosla Kumar

Children: 1

The post Bhushan Kumar Net Worth in 2021 (T-Series Owner) appeared first on MoneyForWallet.

India’s true COVID-19 death toll may be closer to 4 million – 10 times higher than the official count – according to a new study

india coronavirus
A critical patient who tested positive for COVID-19 is been taken to an ICU unit at a COVID-19 care hospital in Kolkata, India, on April 22, 2021.

  • A new study estimated India’s true COVID-19 death toll may be closer to 4 million people.
  • Prime Minister Narendra Modi’s government has been criticized for its handling of the pandemic.
  • Less than 7% of India’s population of 1.4 billion people are vaccinated, according to the report.
  • Visit Insider’s homepage for more stories.

The true COVID-19 death toll in India is close to 4 million people – 10 times higher than the official toll – according to a new study published Tuesday.

The study was conducted by researchers at the Center for Global Development, a research institute based in Washington, DC.

Researchers estimated that, in total, India’s true death toll between January 2020 and June 2021 was between 3.4 and 4.7 million people, with up to 4 million of those deaths being solely due to COVID-19.

India’s official COVID-19 death toll is more than 400,000, The New York Times reported. As of Tuesday, the country also reported 40,000 new COVID-19 cases and close to 500 deaths a day, according to a Times database.

“Estimating Covid deaths with statistical confidence may prove elusive,” the researchers wrote. “But all estimates suggest that the death toll from the pandemic is likely to be an order of magnitude greater than the official count of 400,000; they also suggest that the first wave was more lethal than is believed.”

According to the study, the authors reached their conclusion by analyzing state data in India, serological studies, international estimates, and through a series of household surveys.

With less than 7% of India’s population of 1.4 billion people vaccinated, experts said it could present concerning scenarios.

The Indian government, under Prime Minister Narendra Modi, has been routinely criticized for under-counting COVID-19 deaths during different surges and for refusing lockdown measures. One of the authors of the study formerly served as chief economic adviser to the government during Modi’s term.

“True deaths are likely to be in the several millions, not hundreds of thousands, making this arguably India’s worst human tragedy,” the study’s authors wrote.

Read the original article on Business Insider

India’s true COVID-19 death toll could be as high as 2.4 million, 6 times the official figures, experts warn

india covid mass cremation
A mass cremation of people who died due to COVID-19 in New Delhi, India, on April 22, 2021.

  • Experts believe that India’s COVID-19 death toll is far higher than official numbers suggest.
  • One study estimates that between 1.8m and 2.4m people in India have died from the virus.
  • Reports suggest that Indian officials have attempted to suppress the true figures.
  • See more stories on Insider’s business page.

India’s true COVID-19 death toll could be 5 to 7 times more than the official figures suggest, according to The Economist.

Earlier this year, the country was ravaged by a disastrous second wave of COVID-19, with widespread reports of hospitals overflowing and oxygen shortages.

The Indian health ministry claims that since the start of the pandemic, a little over 411,000 people have lost their lives to the virus. Experts now believe that the official figure is a fraction of the true death toll.

A recent paper by Christopher Leffler of Virginia Commonwealth University in America, cited by The Economist, estimates that between 1.8 million and 2.4 million people have died from COVID-19 since the start of the pandemic.

If true, that would mean India has by far the highest COVID-19 mortalities worldwide. Currently, the US has the highest official death toll, with over 6o0,000 recorded deaths, according to the John Hopkins University.

Another study cited by The Economist, based on insurance claims in the Indian state of Telangana, suggests that the virus death toll could be six times more than the official figures suggest.

The Indian government has rejected these reports, claiming that they are not based on scientific evidence.

india covid second wave
A woman is consoled after her husband died due to the coronavirus disease (COVID-19) outside a mortuary of a COVID-19 hospital in Ahmedabad, India, April 15, 2021.

Yashwant Deshmukh, chairperson of CVoter polling group, told The Economist that the misleading official figures were “not about capacity, but intent.”

“And it’s not about the central government or a particular party. It is about data suppression at every level, no matter who is in charge.”

According to Foreign Policy, the way the Indian government records COVID-19 fatalities has obscured the true death toll.

The first problem, according to the magazine, is that India’s death registration system already under-reported deaths before the pandemic. This is partly because many Indians do not receive medical treatment before passing and many deaths are not medically certified.

But some problems in registering deaths are specific to the pandemic. India’s official guidance states that if a person dies without being tested for the virus or had tested negative but displayed symptoms, their death should be classified as a “suspected or probable COVID-19”.

But officials from several Indian states told Foreign Policy that only people who had tested positive for the virus and then died soon after in hospital, with a clear disease progression, were counted as official COVID-19 deaths.

The magazine added that most states in India had established “death audit committees,” which examine death certificates to determine what should be classed as a COVID-19 death. In some cases, the deaths of people with comorbidities were attributed to those conditions rather than to COVID-19.

India has now mostly overcome its second wave, reporting roughly 40,000 new cases a day, according to John Hopkins University. At its peak, India accounted for roughly half of the world’s COVID-19 cases, according to the World Health Organization.

Read the original article on Business Insider

A giant mural of Elon Musk and Iron Man watches over a co-working space in the Himalayas where digital nomads flock for ‘workation’

elon musk
Elon Musk.

With remote work becoming more normal than ever during coronavirus lockdowns, there are more so-called “digital nomads” than ever before – professionals who moved at least three times in the last year – according to MBO Partners.

So, where are these digital nomads going?

Tulum, Mexico, is a popular destination, but there’s somewhere far more remote for the most dedicated remote workers: the Himalayas. That’s where WorkationX is located, overlooking the mountains of the Kangra District at Rajgundha, India.

The only way to reach the WorkationX compound is a four-hour hike, but visitors who make the trek will be greeted by multiple homages to the closest thing the tech world has to a religious prophet: Tesla CEO Elon Musk.

A mural of Elon Musk with his hands held in prayer next to Marvel's Iron Man in a coworking space in India.
One of the shared workspaces at WorkationX, a co-working space in the Himalayan mountain range.

Musk, next to Iron Man for good measure, is featured with his hands clasped in a prayer position. In this shared working space, a smattering of bean bag chairs have been arranged for improvised seating.

In another spot in the building, over a stairway, Musk is featured as Uncle Sam:

Elon Musk as Uncle Sam as a mural at the WorkationX co-working space in India.
Musk as Uncle Sam.

WorkationX is a co-working space intended for guests to, “work, live and engage with the local community of the Himalayas,” according to the company’s website. “It is a workspace dedicated to the modern day visionary, Elon Musk.”

The grounds have six suites with WiFi for guests, yoga classes, and customized itineraries are offered – everything a digital nomad could ever need.

Got a tip? Contact Insider senior correspondent Ben Gilbert via email (, or Twitter DM (@realbengilbert). We can keep sources anonymous. Use a non-work device to reach out. PR pitches by email only, please.

Read the original article on Business Insider

Coinbase gears up to hire hundreds of engineers in India, with a sweetener of $1,000 in crypto for new starters

Indian flag held by a woman
Indian flag held by a woman

  • Coinbase will recruit hundreds of “world-class” engineers for its new Indian tech hub, it said Friday.
  • New starters will get $1,000 in digital currency, in hopes they’ll use it to learn about crypto.
  • The crypto exchange is also exploring acquisition of start-ups in India as part of the push.
  • Sign up here for our daily newsletter, 10 Things Before the Opening Bell.

Coinbase plans to hire hundreds of engineers and other staff for its tech hub in India, who will each be given $1,000 in cryptocurrency when they start, the crypto exchange company said in a blog post Friday.

A “boom in cryptonative talent” prompted the recruitment spree, Pankaj Gupta, Coinbase’s site lead in India wrote in the post.

The Indian hub, announced in March, will house engineering, software development, IT services and customer support. Employees will work remotely, at first, given pandemic concerns, but Coinbase expects to open its first physical office of many in Hyderabad.

“We have ambitious plans for this hub in the near future – we want to hire hundreds of world class engineers in the near term,” Gupta wrote.

The $1,000 in crypto handed to new employees under the CIkka program – short for “Coinbase India Sikka” – is meant to inspire them to come up with ideas to develop the crypto exchange’s range of services.

“Our expectation is that they’ll leverage this offering to learn about crypto, and will use this knowledge to help us build the next generation of products,” Gupta said.

Coinbase plans to set up locally-led teams in India across all the major areas it works in, from crypto to cloud, to machine learning to platform. While, they will be involved in both global and local projects, crypto investing in India also grew from $923 million until April 2020 to nearly $6.6 billion in May, Bloomberg reported.

“There’s never been a more exciting time for builders working in crypto,” Gupta said.

As part of the expansion in India, Coinbase is looking into possible start-up acquisitions and “acquihires” – where a company is bought to secure its talent – Gupta said.

Crypto adoption has grown worldwide, driven by increased popularity for decentralized finance, smart contracts and non-fungible tokens, which like bitcoin and ether are built on blockchains.

The hiring spree covers senior and junior roles across product management, user experience, design and program management. There will also be a HR and recruitment team.

India marked the next step in the company’s global mission as it has already opened hubs in the US, the UK, Ireland, Japan, Singapore, Canada and the Philippines.

Read the original article on Business Insider

Oman reports new cases of black fungus in COVID-19 patients following ‘epidemic’ of the infection in India

Omani healthcare worker prepares a dose of the Pfizer/BioNTech Covid-19 vaccine at the Sultan Qaboos Sports Complex in Oman's capital Muscat on June 8, 2021.
Omani healthcare worker prepares a dose of the Pfizer/BioNTech Covid-19 vaccine at the Sultan Qaboos Sports Complex in Oman’s capital Muscat on June 8, 2021.

  • Mucorymycosis has been seen in patients with particularly severe cases of COVID-19.
  • The fungal infection has a high mortality rate, requiring the removal of infected tissue.
  • Doctors in Oman have encountered at least three COVID-19 patients with “black fungus,” the AP said.
  • See more stories on Insider’s business page.

Doctors in Oman, a small nation on the Arabian Peninsula, have encountered at least three COVID-19 patients with “black fungus,” the Associated Press reported Tuesday.

The fungal infection, known as mucorymycosis, can be fatal. The news comes as Oman faces a surge in coronavirus cases brought about, in part, by the fact that more than 90% of its population has not yet been vaccinated, according to the AP report.

According to the US Centers for Disease Control and Prevention, people with severe cases of COVID-19 “are particularly vulnerable to bacterial and fungal infections.” The use of “high-dose corticosteroids and tocilizumab,” a monoclonal antibody, can also predispose patients to infection from fungal spores.

Signs of infection include black lesions on the nose or inside the mouth, according to the CDC.

The problem of black fungus has been particularly acute in India, where several states have declared it an epidemic amid the spread of a coronavirus variant officially known as B.1.617, but more recently renamed Delta, that appears to be more contagious than the original. As Insider has reported, black fungus has a 50% mortality rate “and requires all infected tissues to be removed for patients to have a fighting chance.”

Read the original article on Business Insider

The Indian government’s failed vaccine drive has caused thousands of Indians to needlessly die

india vaccine line
People wait in line to receive COVID-19 vaccines in Mumbai, India on April 24, 2021.

  • Modi announced last Monday that vaccines were now free for all adults in India.
  • But private hospitals will still charge for vaccines, and it is unclear whether the government has enough stock of free vaccines.
  • 200,000 Indians have died since the start of the vaccination drive thanks to the government’s mismanagement.
  • Peony Hirwani is a culture and political journalist.
  • This is an opinion column. The thoughts expressed are those of the author.
  • See more stories on Insider’s business page.

In the past five months, Indians have seen thousands of people die due to lack of oxygen, medication, ventilators, and hospital beds. The COVID-19 pandemic has swept the nation with trepidation and has cost Indians more than it should.

Last Monday, Prime Minister Narendra Modi announced that vaccines were free for all adult citizens. As delightful as the news sounds, later clarification showed this wasn’t actually the case. Private hospitals will continue charging for the vaccine, and the supply at government hospitals – where the vaccine is free – has been tragically low so far. From the start, India’s vaccine drive has been terribly mismanaged, costing thousands of Indians their lives.

Not enough people vaccinated

As of June 10, 359,000 Indians have lost their lives to the disease. Some of them could have been saved if the vaccine drive was better managed.

India began its inoculation drive on January 16 when it managed to administer a little less than 200,000 doses to frontline workers. On April 2, the number of administered vaccines rose to 4.3 million doses, and starting May 1, when the government announced vaccinations were available for everyone 18 years and older, the number of administered vaccines, on average, was around one million doses per day – far less than it should be for a country with 1.38 billion people.

As the 18 and older population attempted to sign up for a vaccine appointment on May 1, the registration websites crashed, and when people finally managed to get themselves registered, there were no slots available in most states. (Based on personal experience, the situation is still the same). Modi basically announced the second phase of the biggest vaccine drive in the world while knowing there wasn’t sufficient stock available.

So far, only 5% of eligible adults have been completely vaccinated in India – when we look at the entire population, the percentage drops to 3%.

High cost barrier

One of the primary reasons why more people haven’t gotten their jabs is due to the cost barrier and unavailability of doses.

India’s two leading vaccines, Covaxin and Covishield (AstraZeneca), have been administered to eligible citizens in government hospitals for free, but private institutions have been charging a whopping rate of 800-1400 rupees ($10.92-$19.11) for the jab. It’s next to impossible to register for an appointment at a government facility due to low stock, so most of the population, including me, had to choose the private option. I personally paid 850 rupees for my shot, a price which is completely unaffordable for a lower-wage worker who is looking to get their entire family vaccinated.

“I am so scared of the disease,” Dinesh Ramkumar, a watchman in the state of Rajasthan, told me. “One of our family members got infected a month ago and we spent almost all our savings for his treatment. Now, we were dependent on the government to provide us with free vaccines, but every time I go to the government center, they say that they don’t have any stock left … there’s no way I can pay 1,000 rupees for one vaccine as my family has 10 people, and it would cost me 10,000 rupees.”

Vaccine mismanagement

On Tuesday, after Modi’s announcement the day before that vaccines would be free, the government announced several changes to its vaccine policy, including a new cap on prices that private hospitals can charge. However, in many cases, these caps are higher than what the prices were before. The government has also capped the service charge for getting the shot at 150 rupees – a price which makes the whole thing unviable for the people who need the vaccine most.

Just last week, the US Food and Drug Administration (FDA) dismissed Bharat Biotech’s proposal for emergency use authorization for their Covaxin vaccine in the US. This news has certainly added to the already existing vaccine hesitancy concerns in India. It will also put a strain on India to develop enough doses of Covishield for the country’s population.

The Indian authorities have released a statement saying that Covaxin not getting emergency approval in the US won’t affect India’s vaccine drive, but that likely won’t change how residents see the news.

It’s baffling how mismanaged the entire immunization drive has been from the beginning. How did the world’s biggest antibody producer, dubbed the “pharmacy of the world,” end up with so few vaccines for itself?

More than 200,000 people have died in India since inoculation began. That’s how many lives would have been saved if the authorities had prepared for the second wave by arranging resources, ordering more vaccines, and making them available for free.

We all know that the only way to beat this deadly virus is through vaccines. So, why weren’t we ready? After the declarations this week, it still doesn’t feel like the vaccine has really been made free.

Based on how things have gone, I worry that people still won’t be able to register for the free shots as promised. Is there any meaning attached to Modi’s words? Only time will tell.

Read the original article on Business Insider